SCHEMBL2220948

SCHEMBL2220948

COc1ccc2c(S(=O)(=O)c3ccc(C(F)(F)F)c(NC4CCN(C)CC4)c3)c[nH]c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.41
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KCNH2 Q12809 2/20 0.39
EZH2 Q15910 2/20 0.39
TP53 P04637 1/20 0.38
CDK7 P50613 1/20 0.38
CCNH P51946 1/20 0.38
MNAT1 P51948 1/20 0.38
UTS2R Q9UKP6 3/20 0.38
HTR6 P50406 1/20 0.38
CYP3A4 P08684 3/20 0.37
HTR2A P28223 3/20 0.37
HTR2C P28335 3/20 0.37
DRD2 P14416 2/20 0.37
SLC6A2 P23975 2/20 0.37
HTR7 P34969 2/20 0.37
HRH1 P35367 2/20 0.37
ADRA1B P35368 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2222595 0.93 MAPT (0.50) MAPTLMNAHTTSMN1; SMN2KCNH2
SCHEMBL2221872 0.89 KCNH2 (0.42) KCNH2CDK7CCNHMNAT1HTR6
SCHEMBL2224555 0.88 KCNH2 (0.43) MAPTLMNAHTTSMN1; SMN2KCNH2
SCHEMBL2224015 0.88 CYP3A4 (0.41) KCNH2CDK7CCNHMNAT1CYP3A4
SCHEMBL2224976 0.88 MAPT (0.44) MAPTLMNAHTTSMN1; SMN2KCNH2
SCHEMBL2222673 0.84 CYP3A4 (0.43) MAPTLMNAHTTSMN1; SMN2KCNH2
SCHEMBL2224849 0.83 CYP3A4 (0.43) KCNH2HTR6CYP3A4HTR2AHTR2C
SCHEMBL2223438 0.82 MAPT (0.53) MAPTLMNAHTTSMN1; SMN2KCNH2
SCHEMBL2226273 0.82 MAPT (0.48) MAPTLMNAHTTSMN1; SMN2KCNH2
SCHEMBL2223322 0.81 MAPT (0.53) MAPTLMNAHTTSMN1; SMN2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP claimed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO claimed
US-9018231-B2 Sulfone compounds as 5-HT6 receptor ligands SUVEN LIFE SCIENCES LIMITED (IN) 2015-04-28 US disclosed
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2013-01-03 US disclosed
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP disclosed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS HTR6, HTR5A, HTR1A MAPT 509/4885LMNA 3622/4885HTT 1036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.